These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33235805)

  • 1. Evaluating of HPV-DNA ISH as an adjunct to p16 testing in oropharyngeal cancer.
    Chi J; Preeshagul IR; Sheikh-Fayyaz S; Teckie S; Kohn N; Ziemba Y; Laser A; Frank D; Ghaly M; Kamdar D; Kraus D; Paul D; Seetharamu N
    Future Sci OA; 2020 Aug; 6(9):FSO606. PubMed ID: 33235805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion of an E7 DNA Amplification Test Improves the Robustness of Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma Diagnosis.
    Perera PY; Perera LP; Filkoski L; Chen W; Lichy JH; Paal E; Maxwell JH
    World J Oncol; 2020 Feb; 11(1):1-8. PubMed ID: 32095184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization.
    Pannone G; Rodolico V; Santoro A; Lo Muzio L; Franco R; Botti G; Aquino G; Pedicillo MC; Cagiano S; Campisi G; Rubini C; Papagerakis S; De Rosa G; Tornesello ML; Buonaguro FM; Staibano S; Bufo P
    Infect Agent Cancer; 2012 Feb; 7():4. PubMed ID: 22376902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of p16
    Prigge ES; Arbyn M; von Knebel Doeberitz M; Reuschenbach M
    Int J Cancer; 2017 Mar; 140(5):1186-1198. PubMed ID: 27859245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RB1, p16, and Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma.
    Berdugo J; Rooper LM; Chiosea SI
    Head Neck Pathol; 2021 Dec; 15(4):1109-1118. PubMed ID: 33830464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ hybridization for high-risk HPV E6/E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancer.
    Randén-Brady R; Carpén T; Jouhi L; Syrjänen S; Haglund C; Tarkkanen J; Remes S; Mäkitie A; Mattila PS; Silén S; Hagström J
    Hum Pathol; 2019 Aug; 90():97-105. PubMed ID: 31121191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplex HPV RNA in situ hybridization/p16 immunohistochemistry: a novel approach to detect papillomavirus in HPV-related cancers. A novel multiplex ISH/IHC assay to detect HPV.
    Zito Marino F; Ronchi A; Stilo M; Cozzolino I; La Mantia E; Colacurci N; Colella G; Franco R
    Infect Agent Cancer; 2020; 15():46. PubMed ID: 32684947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of Cervista Human Papillomavirus 16/18 Assay Into Algorithms for Classifying Human Papillomavirus Status in Formalin-Fixed, Paraffin-Embedded Head and Neck Squamous Carcinoma Specimens.
    Guo M; Khanna A; Wang J; Williams MD; Kalhor N; Gong Y; Xu L; Sturgis EM; Staerkel G
    Arch Pathol Lab Med; 2019 Mar; 143(3):356-361. PubMed ID: 30221979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Catenin Expression in Oropharyngeal Squamous Cell Carcinomas: Comparison and Correlation with p16 and Human Papillomavirus in situ Hybridization.
    Nwanze J; Cohen C; Schmitt AC; Siddiqui MT
    Acta Cytol; 2015; 59(6):479-84. PubMed ID: 26849661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ hybridization for high risk HPV E6/E7 mRNA in oropharyngeal squamous cell carcinoma.
    Suresh K; Shah PV; Coates S; Alexiev BA; Samant S
    Am J Otolaryngol; 2021; 42(1):102782. PubMed ID: 33171410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of high-risk human papillomavirus E6/E7 mRNA in situ hybridization in assessing HPV status on cell block.
    Wilson BL; Israel AK; Lott Limbach AA
    J Am Soc Cytopathol; 2021; 10(2):225-230. PubMed ID: 33092993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice.
    Thavaraj S; Stokes A; Guerra E; Bible J; Halligan E; Long A; Okpokam A; Sloan P; Odell E; Robinson M
    J Clin Pathol; 2011 Apr; 64(4):308-12. PubMed ID: 21345874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of p16 as a surrogate marker for transcriptionally active human papillomavirus status of oropharyngeal squamous cell carcinoma in an eastern Chinese population.
    Xu S; Sun B; Zhou R; Shi C; Han Y; Li J; Sun J; Tian Z; Zhang Z; Li J
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Mar; 129(3):236-245.e2. PubMed ID: 31987673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of transcriptionally active HPV infection in formalin-fixed, paraffin-embedded biopsies of oropharyngeal carcinoma.
    Morbini P; Alberizzi P; Tinelli C; Paglino C; Bertino G; Comoli P; Pedrazzoli P; Benazzo M
    Hum Pathol; 2015 May; 46(5):681-9. PubMed ID: 25708613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of local p16 testing for determination of human papilloma virus status eligibility on a low risk oropharyngeal cancer trial - A Trans-Tasman Radiation Oncology Group study.
    Young RJ; Solomon B; Corry J; Angel C; Kenny L; Porceddu S; Wratten C; Macann A; Jackson JE; Herschtal A; Rischin D
    Oral Oncol; 2020 Nov; 110():104988. PubMed ID: 32889172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong SOX10 expression in human papillomavirus-related multiphenotypic sinonasal carcinoma: report of 6 new cases validated by high-risk human papillomavirus mRNA in situ hybridization test.
    Hsieh MS; Lee YH; Jin YT; Huang WC
    Hum Pathol; 2018 Dec; 82():264-272. PubMed ID: 30071233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepancy of p16 immunohistochemical expression and HPV RNA in penile cancer. A multiplex in situ hybridization/immunohistochemistry approach study.
    Zito Marino F; Sabetta R; Pagliuca F; Brunelli M; Aquino G; Perdonà S; Botti G; Facchini G; Fiorentino F; Di Lauro G; De Sio M; De Vita F; Toni G; Borges Dos Reis R; Neder L; Franco R
    Infect Agent Cancer; 2021 Mar; 16(1):22. PubMed ID: 33789689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
    Nopmaneepaisarn T; Tangjaturonrasme N; Rawangban W; Vinayanuwattikun C; Keelawat S; Bychkov A
    BMC Cancer; 2019 Nov; 19(1):1050. PubMed ID: 31694600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine-needle aspiration of cervical lymph nodes yields adequate materials for accurate HPV testing in metastatic head and neck squamous cell carcinomas.
    Hou Y; Chaudhary S; Shen R; Li Z
    Diagn Cytopathol; 2016 Oct; 44(10):792-8. PubMed ID: 27465660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials.
    Jordan RC; Lingen MW; Perez-Ordonez B; He X; Pickard R; Koluder M; Jiang B; Wakely P; Xiao W; Gillison ML
    Am J Surg Pathol; 2012 Jul; 36(7):945-54. PubMed ID: 22743284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.